DART

Welcome to the Brand page for “DART”, which is offered here for Pharmaceutical preparation in the form of a genetic vector used in connection with gene therapy for applications involving angiogenesis, anti-angiogenesis or tissue transplantation or for prophylaxis or treatment of cancer or other hyperplasic disorders, ocular disorders, vascular disorders, coronary disorders, neurological disorders, reproductive disorders, muscular disorders, skeletal disorders, ear or hearing disorders, endocrine disorders, dermatological disorders or infectious diseases;.

Its status is currently believed to be active. Its class is unavailable. “DART” is believed to be currently owned by “GenVec, Inc.”